R1	AND Arg1:T2 Arg2:T1	
R2	Has_temporal Arg1:T2 Arg2:T3	
R3	Has_qualifier Arg1:T7 Arg2:T6	
R4	Has_multiplier Arg1:T10 Arg2:T9	
R5	Has_temporal Arg1:T10 Arg2:T11	
*	OR T13 T12
R6	Has_qualifier Arg1:T15 Arg2:T14	
*	OR T4 T7
R9	Has_temporal Arg1:T4 Arg2:T8	
R10	AND Arg1:T4 Arg2:T10	
R7	Subsumes Arg1:T4 Arg2:T15	
R8	Has_qualifier Arg1:T4 Arg2:T14	
R11	Has_temporal Arg1:T20 Arg2:T19	
R12	AND Arg1:T18 Arg2:T20	
R13	Has_qualifier Arg1:T18 Arg2:T17	
*	OR T21 T22
R14	AND Arg1:T23 Arg2:T21	
R15	Has_temporal Arg1:T26 Arg2:T27	
R16	AND Arg1:T26 Arg2:T28	
R17	Has_negation Arg1:T26 Arg2:T29	
R18	Has_qualifier Arg1:T38 Arg2:T42	
R19	Has_qualifier Arg1:T39 Arg2:T43	
R20	Has_qualifier Arg1:T40 Arg2:T44	
R21	Has_qualifier Arg1:T41 Arg2:T45	
R22	Has_temporal Arg1:T48 Arg2:T49	
R23	Has_negation Arg1:T48 Arg2:T47	
R24	AND Arg1:T46 Arg2:T48	
R25	Has_mood Arg1:T51 Arg2:T52	
R26	Has_qualifier Arg1:T54 Arg2:T56	
*	OR T57 T58 T59
R27	Subsumes Arg1:T54 Arg2:T57	
R28	Has_temporal Arg1:T54 Arg2:T55	
R29	Has_temporal Arg1:T5 Arg2:T8	
R30	AND Arg1:T5 Arg2:T10	
R31	Subsumes Arg1:T5 Arg2:T15	
R32	Has_qualifier Arg1:T5 Arg2:T14	
T1	Condition 4 6	MS
T2	Condition 7 14	relapse
T3	Temporal 15 37	in the last five years
T4	Condition 116 131	T2/FLAIR lesion
T5	Drug 139 149	gadolinium
T6	Qualifier 139 159	gadolinium-enhancing
T7	Condition 160 166	lesion
T8	Temporal 167 194	within the past three years
T9	Multiplier 196 208	at least two
T10	Procedure 209 214	scans
T11	Temporal 215 248	separated by at least three years
T12	Procedure 279 293	spine MRI scan
T13	Procedure 270 275;285 293	brain MRI scan
T14	Qualifier 311 324	3mm or larger
T15	Condition 295 302	Lesions
T17	Qualifier 346 357	Significant
T18	Condition 381 392	intolerance
T19	Temporal 396 410	presently-used
T20	Drug 411 414	DMT
T21	Drug 423 430;442 450	inhaled steroids
T22	Drug 434 450	topical steroids
T23	Negation 455 458	not
T25	Non-representable 416 481	Use of inhaled or topical steroids are not an exclusion criteria.
T26	Drug 490 503	oral steroids
T27	Temporal 508 531	no greater than 14 days
T28	Condition 544 560	non-MS condition
T29	Negation 564 567	not
T30	Non-representable 483 581	Use of oral steroids for no greater than 14 days given for a non-MS condition is not exclusionary.
T31	Drug 583 594	alemtuzumab
T32	Drug 597 609	mitoxantrone
T33	Drug 612 628	cyclophosphamide
T34	Drug 631 643	methotrexate
T35	Drug 646 658	cyclosporine
T36	Drug 664 673	rituximab
T37	Non-query-able 675 754	Prior use of any experimental agent used as a DMT for MS in the last five years
T38	Condition 769 781	hypertension
T39	Condition 797 805	diabetes
T40	Condition 821 827	asthma
T41	Condition 846 856	depression
T42	Qualifier 756 768	uncontrolled
T43	Qualifier 784 796	uncontrolled
T44	Qualifier 808 820	uncontrolled
T45	Qualifier 833 845	uncontrolled
T46	Condition 858 865	Cancers
T47	Negation 866 876	other than
T48	Condition 877 900	basal cell skin cancers
T49	Temporal 901 924	within the last 5 years
T50	Non-query-able 926 980	Unable to give informed consent or follow the protocol
T51	Procedure 1000 1009	brain MRI
T52	Mood 982 999	Unable to undergo
T53	Post-eligibility 1011 1055	Unwilling to be randomized per this protocol
T54	Condition 1074 1104	chronic neurological illnesses
T55	Temporal 1057 1067	History of
T56	Qualifier 1116 1124	mimic MS
T57	Condition 1169 1172	ALS
T58	Condition 1174 1191	myasthenia gravis
T59	Condition 1193 1211	chronic neuropathy
